Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study

NCT03640884 is registered in ClinicalTrials.gov with Zhong Wang as lead sponsor.

NCT NCT03640884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03640884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study
Lead sponsor
Zhong Wang
Phase
Observational
Overall status
Unknown status
Start date
February 18, 2019
Completion date
June 30, 2022
Enrollment
30,000 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug event, adverse drug reactions, anaphylactic reaction, severe adverse reactions